| Ambetter Health Texas Superior Marketplace Clinical | Bevacizumab and Biosimilars | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Brand Name Override and Non-Formulary Medications | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Brensocatib | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Brivaracetam | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Calcipotriene/Betamethasone Dipropionate Foam | 2025-11-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Canakinumab | 2025-11-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Daunorubicin/Cytarabine | 2025-11-01 |
| Ambetter Health Texas Superior Medicaid Clinical | DaxibotulinumtoxinA-lanm | 2025-11-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Denileukin Diftitox-cxdl | 2025-11-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Denosumab and Biosimilars | 2025-11-01 |